Collaboration aims to leverage Polyrizon’s advanced proprietary intranasal delivery platform to support clinical development of Clearmind’s drug candidate proprietary MEAI Raanana, Israel, Feb. 06, ...
Your genetics (traits passed from parents to children) and family history can increase your risk of developing depression. The condition is about 40% heritable (meaning there's a 40% chance of ...
Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety medication. Phase 1 clinical trial of the patent-pending, rapid-onset ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results